FundamentalVR

The company's core offering is the Fundamental Surgery platform, a Software-as-a-Service (SaaS) solution that combines virtual reality (VR) with haptic feedback to allow medical professionals to experience the sights, sounds, and physical sensations of real-life surgery. Its patented HapticVR™ technology mimics the feeling of tissue textures, the weight of tools, and resistance, which is crucial for developing muscle memory. In May 2024, the company integrated advanced AI and machine learning capabilities into the platform to provide real-time data assessments, predictive analytics on user performance, and personalized guidance.

FundamentalVR serves a diverse client base that includes medical device and pharmaceutical companies, hospitals, and medical schools. Its platform helps these clients with product rollouts, skills development, and compliance training. Notable partners and clients include Mayo Clinic, UCLA Health, Teleflex, and Novartis. The business model is primarily subscription-based, offering a scalable and hardware-agnostic platform that can be used on standalone headsets like the Oculus Quest or through full haptic simulators.

The company has achieved significant milestones, including educational accreditation from institutions like the Royal College of Surgeons of England and the American Academy of Orthopaedic Surgeons. Since its founding, FundamentalVR has raised over $30 million in funding through multiple rounds, including a $20 million Series B round in August 2022 led by EQT Life Sciences. This capital is being used to further develop its HapticVR™ technology, expand its data insights product, and accelerate its expansion in the United States.